Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement

References

• Anderson HD, Pace WD, Libby AM, West DR, Valuck RJ. 2012. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther. 34:113–123.
   PubMed Web of Science ®Google Scholar
• Anglin R, Moayyedi P, Leontiadis GI. 2015. Anti-inflammatory Intervention in Depression. JAMA Psychiatry. 72:512.
   PubMedGoogle Scholar
• Angst J. 1998. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 13 Suppl 6:S1–S4.
   PubMed Web of Science ®Google Scholar
• Antonioli M, Rybka J, Carvalho LA. 2012. Neuroimmune endocrine effects of antidepressants. Neuropsychiatr Dis Treat. 8:65–83.
   PubMed Web of Science ®Google Scholar
• Bailey DE, JR., Landerman L, Barroso J, Bixby P, Mishel MH, muir AJ, Strickland L, Clipp E. 2009. Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C. Psychosomatics. 50:138–146.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Lau WK, Sim J, Sum MY, Sim K. 2017. Suicidal risks in reports of long-term controlled trials of antidepressants for major depressive disorder II. Int J Neuropsychopharmacol. 20:281–284.
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Palazzo MC, Masdrakis VG. 2013. Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants. Depress Res Treat. 2013:256841.
   PubMedGoogle Scholar
• Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, et al. 2012. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 378:403–411.
   Web of Science ®Google Scholar
• Barr AM, Markou A, Phillips AG. 2002. A ’crash’ course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci. 23:475–482.
   PubMed Web of Science ®Google Scholar
• Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Moller HJ. 2007. World Federation of Societies of biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry. 8:67–104.
   PubMed Web of Science ®Google Scholar
• Bauer M, Goetz T, Glenn T, Whybrow PC. 2008. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 20:1101–1114.
   PubMed Web of Science ®Google Scholar
• Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Moller HJ. 2013. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 14:334–385.
   PubMed Web of Science ®Google Scholar
• Bauer M, Severus E, Kohler S, Whybrow PC, Angst J, Moller HJ. 2015. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry 16:76–95.
   PubMed Web of Science ®Google Scholar
• Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ. 2002a. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3:5–43.
   PubMedGoogle Scholar
• Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ. 2002b. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry. 3:69–86.
   PubMedGoogle Scholar
• Berk M, Berk L, Castle D. 2004. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord. 6:504–518.
   PubMed Web of Science ®Google Scholar
• Berk M, Dodd S, Malhi GS. 2005. ’Bipolar missed states’: the diagnosis and clinical salience of bipolar mixed states. Aust N Z J Psychiatry. 39:215–221.
   PubMed Web of Science ®Google Scholar
• Berk M, Parker G. 2009. The elephant on the couch: side-effects of psychotherapy. Aust N Z J Psychiatry. 43:787–794.
   PubMed Web of Science ®Google Scholar
• Berk M, Stein DJ, Potgieter A, Maud CM, Els C, Janet ML, Viljoen E. 2000. Serotonergic targets in the treatment of antidepressant induced sexual dysfunction: a pilot study of granisetron and sumatriptan. Int Clin Psychopharmacol. 15:291–295.
   PubMed Web of Science ®Google Scholar
• Berken GH, Weinstein DO, Stern WC. 1984. Weight gain. A side-effect of tricyclic antidepressants. J Affect Disord. 7:133–138.
   PubMed Web of Science ®Google Scholar
• Berlin I, Payan C, Corruble E, Puech AJ. 1999. Serum thyroid-stimulating-hormone concentration as an index of severity of major depression. Int J Neuropsychopharmacol. 2:105–110.
   PubMed Web of Science ®Google Scholar
• Bet PM, Hugtenburg JG, Penninx BW, Hoogendijk WJ. 2013. Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol. 23:1443–1451.
   PubMed Web of Science ®Google Scholar
• Beyondblue. 2011. Clinical practice guidelines for depression and related disorders – anxiety, bipolar disorder and puerperal psychosis – in the perinatal period. A guideline for primary care health professionals. Melbourne: beyondblue: the national depression initiative. Available: https://www.beyondblue.org.au/resources/health-professionals/clinical-practice-guidelines/perinatal-clinical-practice-guidelines.
   Google Scholar
• Bismuth-Evenzal Y, Gonopolsky Y, Gurwitz D, Iancu I, Weizman A, Rehavi M. 2012. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs. J Affect Disord. 136:99–103.
   PubMed Web of Science ®Google Scholar
• Blumenthal SR, Castro VM, Clements CC, Rosenfield HR, Murphy SN, Fava M, Weilburg JB, Erb JL, Churchill SE, KOHANE IS, et al. 2014. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry. 71:889–896.
   PubMed Web of Science ®Google Scholar
• Bousman CA, Hopwood M. 2016. Commercial pharmacogenetic-based decision-support tools in psychiatry. Lancet Psychiatry. 3:585–590.
   PubMed Web of Science ®Google Scholar
• Boyer EW, Shannon M. 2005. The serotonin syndrome. N Engl J Med. 352:1112–1120.
   PubMed Web of Science ®Google Scholar
• Brennan FX, Gardner KR, Lombard J, Perlis RH, Fava M, Harris HW, Scott R. 2015. A naturalistic study of the effectiveness of pharmacogenetic testing to guide treatment in psychiatric patients with mood and anxiety disorders. Prim Care Companion CNS Disord. 17. doi:10.4088/PCC.14m01717
   PubMedGoogle Scholar
• Buckley NA, Faunce TA. 2003. ’Atypical’ antidepressants in overdose: clinical considerations with respect to safety. Drug Saf. 26:539–551.
   PubMed Web of Science ®Google Scholar
• Carta MG, Hardoy MC, Garofalo A, Pisano E, Nonnoi V, Intilla G, Serra G, Balestrieri C, Chessa L, Cauli C, et al. 2007. Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemol Ment Health. 3:22.
   PubMedGoogle Scholar
• Carvajal Garcia-Pando A, Garcia del Pozo J, Sanchez AS, Velasco MA, Rueda de Castro AM, Lucena MI. 2002. Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry. 63:135–137.
   PubMed Web of Science ®Google Scholar
• Castro VM, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Iosifescu DV, et al. 2013. QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ. 346:f288.
   PubMed Web of Science ®Google Scholar
• Clayton AH, Mcgarvey EL, Clavet GJ. 1997. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 33:731–745.
   PubMed Web of Science ®Google Scholar
• Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, et al. 2015. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 29:459–525.
   PubMed Web of Science ®Google Scholar
• Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J. 2011. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess. 15:1–202. iii-iv.
   PubMed Web of Science ®Google Scholar
• Culpepper L, Davidson JR, Dietrich AJ, Goodman WK, Kroenke K, Schwenk TL. 2004. Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry. 65:742–749.
   PubMed Web of Science ®Google Scholar
• Davis JD, Tremont G. 2007. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol. 32:49–65.
   PubMedGoogle Scholar
• Deligiannidis KM, Byatt N, Freeman MP. 2014. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 34:244–255.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K. 2011. Agomelatine: a narrative review. Eur Neuropsychopharmacol. 21 Suppl 4:S703–S709.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Corruble E, Hale A, Quera-Salva MA, Picarel-Blanchot F, Kasper S. 2013. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. CNS Spectr. 18:163–170.
   PubMed Web of Science ®Google Scholar
• Dodd S, Berk M. 2004. Predictors of antidepressant response: a selective review. Int J Psychiatry Clin Pract. 8:91–100.
   PubMed Web of Science ®Google Scholar
• Dodd S, Buist A, Norman TR. 2000a. Antidepressants and breast-feeding: a review of the literature. Paediatr Drugs. 2:183–192.
   PubMedGoogle Scholar
• Dodd S, Horgan D, Malhi GS, Berk M. 2005. To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord. 89:1–11.
   PubMed Web of Science ®Google Scholar
• Dodd S, Malhi GS, Tiller J, Schweitzer I, Hickie I, Khoo JP, Bassett DL, Lyndon B, Mitchell PB, Parker G, et al. 2011. A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Aust N Z J Psychiatry. 45:712–725.
   PubMed Web of Science ®Google Scholar
• Dodd S, Schacht A, Kelin K, Duenas H, Reed VA, Williams LJ, Quirk FH, Malhi GS, Berk M. 2015. Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials. J Clin Psychiatry 76:702–711.
   PubMed Web of Science ®Google Scholar
• Dodd S, Stocky A, Buist A, Burrows GD, Maguire K, Norman TR. 2000b. Sertraline in paired blood plasma and breast-milk samples from nursing mothers. Hum Psychopharmacol. 15:161–264.
   PubMed Web of Science ®Google Scholar
• Dziukas LJ, Vohra J. 1991. Tricyclic antidepressant poisoning. Med J Aust. 154:344–350.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency 2008. Valdoxan: EPAR – Product Information. Downloaded from www.ema.europa.eu/docs/en_GB/…Product_Information/…/WC500046227.pdf Doc.Ref.: EMEA/655251/2008. 20 November 2008 ed.
   Google Scholar
• Fava M. 2000. Weight gain and antidepressants. J Clin Psychiatry. 61 Suppl 11:37–41.
   PubMed Web of Science ®Google Scholar
• Fava M, Dording CM, Baker RA, Mankoski R, Tran QV, Forbes RA, Eudicone JM, Owen R, Berman RM. 2011. Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies. Prim Care Companion CNS Disord. 13. doi:10.4088/PCC.10m00994gre
   PubMedGoogle Scholar
• Fava M, Labbate LA, Abraham ME, Rosenbaum JF. 1995. Hypothyroidism and hyperthyroidism in major depression revisited. J Clin Psychiatry. 56:186–192.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Hodge JM, Pasco JA, Berk M, Williams LJ. 2016. Effects of depression and serotonergic antidepressants on bone: mechanisms and implications for the treatment of depression. Drugs Aging. 33:21–25.
   PubMed Web of Science ®Google Scholar
• Fontana RJ, Seeff LB, Andrade RJ, Bjornsson E, Day CP, Serrano J, Hoofnagle JH. 2010. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 52:730–742.
   PubMedGoogle Scholar
• Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S. 2000. Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991-1997: the favourable consequences of the increasing use of SSRIs. Eur Neuropsychopharmacol. 10:133–142.
   PubMed Web of Science ®Google Scholar
• Friedman RA. 2014. Antidepressants’ black-box warning-10 years later. N Engl J Med. 371:1666–1668.
   PubMed Web of Science ®Google Scholar
• Friedrich ME, Akimova E, Huf W, Konstantinidis A, Papageorgiou K, Winkler D, Toto S, Greil W, Grohmann R, Kasper S. 2016. Drug-induced liver injury during antidepressant treatment: results of AMSP, a drug surveillance program. Int J Neuropsychopharmacol. 19:pyv126.
   PubMed Web of Science ®Google Scholar
• Gavin DR, Ross HE, Skinner HA. 1989. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict. 84:301–307.
   PubMedGoogle Scholar
• Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ. 2012. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 69:580–587.
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ. 2007. Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 164:1356–1363.
   PubMed Web of Science ®Google Scholar
• Ginsberg LD. 2009. Impact of drug tolerability on the selection of antidepressant treatment in patients with major depressive disorder. CNS Spectr. 14:8–14.
   PubMed Web of Science ®Google Scholar
• Giorlando F, Teister J, Dodd S, Udina M, Berk M. 2013. Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs. Curr Drug Saf. 8:175–180.
   PubMedGoogle Scholar
• Goldberg JF, Ernst CL. 2012. Managing the side effects of psychotropic medications. Arlington (VA): American Psychiatric Publishing.
   Google Scholar
• Grundy A, Cotterchio M, Kirsh VA, Kreiger N. 2014. Associations between anxiety, depression, antidepressant medication, obesity and weight gain among Canadian women. PLoS One. 9:e99780.
   PubMed Web of Science ®Google Scholar
• Hamer M, Batty GD, Seldenrijk A, Kivimaki M. 2011. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J. 32:437–442.
   PubMed Web of Science ®Google Scholar
• Hammad TA, Laughren T, Racoosin J. 2006. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 63:332–339.
   PubMed Web of Science ®Google Scholar
• Heiskanen TH. 2015. Treatment for depression and the risk of weight gain. J Clin Psychiatry. 76:e828–e829.
   PubMed Web of Science ®Google Scholar
• Henry JA, Alexander CA, Sener EK. 1995. Relative mortality from overdose of antidepressants. BMJ. 310:221–224.
   PubMed Web of Science ®Google Scholar
• Hiemke C. 2008. Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises? Eur Arch Psychiatry Clin Neurosci. 258 Suppl 1:21–27.
   PubMed Web of Science ®Google Scholar
• Hodge JM, Wang Y, Berk M, Collier FM, Fernandes TJ, Constable MJ, Pasco JA, Dodd S, Nicholson GC, Kennedy RL, et al. 2013. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry. 74:32–39.
   PubMed Web of Science ®Google Scholar
• International Society Of Psychiatric Genetics. 2016. Genetic Testing Statement. http://ispg.net/genetic-testing-statement/ [Online]. Brentwood, TN. [Accessed].
   Google Scholar
• Iosifescu DV, Howarth S, Alpert JE, Nierenberg AA, Worthington JJ, Fava M. 2001. T3 blood levels and treatment outcome in depression. Int J Psychiatry Med. 31:367–373.
   PubMed Web of Science ®Google Scholar
• Jacobsen PL, Mahableshwarkar AR, Palo WA, Chen Y, Dragheim M, Clayton AH. 2016. Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis. CNS Spectr. 21:367–378.
   PubMed Web of Science ®Google Scholar
• Jasiak NM, Bostwick JR. 2014. Risk of QT/QTc prolongation among newer non-SSRI antidepressants. Ann Pharmacother. 48:1620–1628.
   PubMed Web of Science ®Google Scholar
• Joffe P, Larsen FS, Pedersen V, Ring-Larsen H, Aaes-Jorgensen T, Sidhu J. 1998. Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects. Eur J Clin Pharmacol. 54:237–242.
   PubMed Web of Science ®Google Scholar
• Jung YE, Jun TY, Kim KS, Bahk WM. 2011. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder. Int J Clin Pharmacol Ther. 49:437–443.
   PubMed Web of Science ®Google Scholar
• Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. 2004. Efficacy and safety of antidepressants for children and adolescents. BMJ. 328:879–883.
   PubMed Web of Science ®Google Scholar
• Karol DE, Criscione-Schreiber LG, Lin M, Clowse ME. 2013. Depressive symptoms and associated factors in systemic lupus erythematosus. Psychosomatics. 54:443–450.
   PubMed Web of Science ®Google Scholar
• Keefe RS, Mcclintock SM, Roth RM, Doraiswamy PM, Tiger S, Madhoo M. 2014. Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. J Clin Psychiatry. 75:864–876.
   PubMed Web of Science ®Google Scholar
• Keitner GI. 2010. Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events. Evid Based Med. 15:19–20.
   PubMedGoogle Scholar
• Kennedy SH, Lam RW, Mcintyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, Macqueen GM, et al. 2016. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Can J Psychiatry. 61:540–560.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. J Affect Disord. 117 Suppl 1:S1–S2.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Rizvi SJ, Fulton K, Ellis J, Quilty LC, Ravindran L. 2010. The sex effects scale: pilot validation in a healthy population. Psychopharmacol Bull. 43:15–25.
   PubMedGoogle Scholar
• Kerr GW, Mcguffie AC, Wilkie S. 2001. Tricyclic antidepressant overdose: a review. Emerg Med J. 18:236–241.
   PubMed Web of Science ®Google Scholar
• Kloiber S, Ising M, Reppermund S, Horstmann S, Dose T, Majer M, Zihl J, Pfister H, Unschuld PG, Holsboer F, et al. 2007. Overweight and obesity affect treatment response in major depression. Biol Psychiatry. 62:321–326.
   PubMed Web of Science ®Google Scholar
• Kogoj A. 2014. Selective serotonin reuptake inhibitors-induced delirium: a case review. Psychiatr Danub. 26:277–280.
   PubMed Web of Science ®Google Scholar
• Kohler S, Buntinx F, Palmer K, Van den Akker M. 2015. Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study. J Am Geriatr Soc. 63:692–698.
   PubMed Web of Science ®Google Scholar
• Koski A, Vuori E, Ojanpera I. 2005. Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med. 119:344–348.
   PubMed Web of Science ®Google Scholar
• Kruger MJ, Nell TA. 2017. Bone mineral density in people living with HIV: a narrative review of the literature. AIDS Res Ther. 14:35.
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, Grigoriadis S, Mcintyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 117 Suppl 1:S26–S43.
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, Parikh SV, Macqueen GM, Milev RV, Ravindran AV. 2016. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: introduction and methods. Can J Psychiatry. 61:506–509.
   PubMed Web of Science ®Google Scholar
• Lane RM. 1998. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol (Oxford). 12:192–214.
   PubMed Web of Science ®Google Scholar
• Lavin MR, Mendelowitz A, Kronig MH. 1993. Spontaneous hypertensive reactions with monoamine oxidase inhibitors. Biol Psychiatry. 34:146–151.
   PubMed Web of Science ®Google Scholar
• Leong C. 2014. Antidepressants for depression in patients with dementia: a review of the literature. Consult Pharm. 29:254–263.
   PubMedGoogle Scholar
• Levin GM, Devane CL. 1992. A review of cyclic antidepressant-induced blood dyscrasias. Ann Pharmacother. 26:378–383.
   PubMed Web of Science ®Google Scholar
• Lucaciu LA, Dumitrascu DL. 2015. Depression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatment. Ann Gastroenterol. 28:440–447.
   PubMed Web of Science ®Google Scholar
• Lucena MI, Carvajal A, Andrade RJ, velasco A. 2003. Antidepressant-induced hepatotoxicity. Expert Opin Drug Saf 2:249–262.
   PubMedGoogle Scholar
• Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. 2010. Extrapyramidal symptoms associated with antidepressants–a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry. 22:148–156.
   PubMed Web of Science ®Google Scholar
• Maes M. 2009. “Functional” or “psychosomatic” symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression. Neuro Endocrinol Lett. 30:564–573.
   PubMed Web of Science ®Google Scholar
• Mago R, Mahajan R, Thase ME. 2008. Medically serious adverse effects of newer antidepressants. Curr Psychiatry Rep. 10:249–257.
   PubMedGoogle Scholar
• Marano G, Traversi G, Romagnoli E, Catalano V, Lotrionte M, Abbate A, Biondi-Zoccai G, Mazza M. 2011. Cardiologic side effects of psychotropic drugs. J Geriatr Cardiol. 8:243–253.
   PubMedGoogle Scholar
• Martinez-Cortes M, Ogando-Portilla N, Pecino-Esquerdo B, Perez-Macia V. 2013. Antidepressant induced recurrent hyponatremia: a case report. Actas Esp Psiquiatr. 41:361–364.
   PubMed Web of Science ®Google Scholar
• Mazzoglio Y Nabar MJ, Muniz MM, Mejias Delamano AA, Munoz S, Magrath Guimet N. 2015. [Ssri and Bone Metabolism in Hiv + Patients with Antiretroviral Therapy]. Vertex. 26:202–210. Spanish.
   PubMedGoogle Scholar
• Mcgahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, Mcknight KM, Manber R. 2000. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 26:25–40.
   PubMed Web of Science ®Google Scholar
• Mcintyre RS, Suppes T, Tandon R, Ostacher MJ. 2017. Florida best practice psychotherapeutic medication guidelines for adults with major depressive disorder. J Clin Psychiatry. 78:703–713.
   PubMed Web of Science ®Google Scholar
• Menear M, Dore I, Cloutier AM, Perrier L, Roberge P, Duhoux A, Houle J, Fournier L. 2015a. Chronic physical comorbidity burden and the quality of depression treatment in primary care: a systematic review. J Psychosom Res. 78:314–323.
   PubMed Web of Science ®Google Scholar
• Menear M, Dore I, Cloutier AM, Perrier L, Roberge P, Duhoux A, Houle J, Fournier L. 2015b. The influence of comorbid chronic physical conditions on depression recognition in primary care: a systematic review. J Psychosom Res. 78:304–313.
   PubMed Web of Science ®Google Scholar
• Menkes DB, Herxheimer A. 2014. Interaction between antidepressants and alcohol: signal amplification by multiple case reports. Int J Risk Saf Med. 26:163–170.
   PubMedGoogle Scholar
• Miller AH, Silberstein C, Asnis GM, Munk G, Rubinson E, Spigland I, Norin A. 1986. Epstein-Barr virus infection and depression. J Clin Psychiatry. 47:529–530.
   PubMed Web of Science ®Google Scholar
• Miller GE, Freedland KE, Duntley S, Carney RM. 2005. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 95:317–321.
   PubMed Web of Science ®Google Scholar
• Moller M, Thayssen P, Kragh-Sorensen P, Pedersen OL, Kristensen CB, Bjerre M, Benjaminsen S, Gram LF. 1983. Mianserin: cardiovascular effects in elderly patients. Psychopharmacology (Berl.) 80:174–177.
   PubMed Web of Science ®Google Scholar
• Montejo AL, Rico-Villademoros F. 2008. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther. 34:227–239.
   PubMed Web of Science ®Google Scholar
• Muller DJ, Kekin I, Kao AC, Brandl EJ. 2013. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic. Int Rev Psychiatry. 25:554–571.
   PubMed Web of Science ®Google Scholar
• Murray KO, Resnick M, Miller V. 2007. Depression after infection with West Nile virus. Emerging Infect Dis. 13:479–481.
   PubMed Web of Science ®Google Scholar
• Nagler EV, Vanmassenhove J, Van Der Veer SN, Nistor I, Van Biesen W, Webster AC, Vanholder R. 2014. Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC Med. 12:1.
   PubMed Web of Science ®Google Scholar
• National Institute for Health Care and Excellence. 2014. NICE guidelines [CG192]. Antenatal and postnatal mental health: clinical management and service guidance. http://www.nice.org.uk/guidance/cg192. [Accessed 19th Nov 2015].
   Google Scholar
• Nemeroff CB, Devane CL, Pollock BG. 1996. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 153:311–320.
   PubMed Web of Science ®Google Scholar
• Nolan MS, Hause AM, Murray KO. 2012. Findings of long-term depression up to 8 years post infection from West Nile virus. J Clin Psychol. 68:801–808.
   PubMed Web of Science ®Google Scholar
• Noordam R, Aarts N, Tiemeier H, Hofman A, Stricker BH, Visser LE. 2015. Sex-specific association between antidepressant use and body weight in a population-based study in older adults. J Clin Psychiatry. 76:e745–e751.
   PubMed Web of Science ®Google Scholar
• O’Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. 1998. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ. 317:982–984.
   PubMed Web of Science ®Google Scholar
• O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, Stough WG, Arias RM, Rivelli SK, et al. 2010. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol. 56:692–699.
   PubMed Web of Science ®Google Scholar
• OECD. 2013. Health at a Glance 2013: OECD Indicators. Paris: OECD Publishing. http://dx.doi.org/10.1787/health_glance-2013-en accessed 23rd April 2015 from http://www.oecd.org/./Health-at-a-Glance-2013.pdf [Online].
   Google Scholar
• Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, Cansever A, Uzun O, Ozgen F, Ozsahin A. 2008. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Hum Psychopharmacol. 23:321–326.
   PubMed Web of Science ®Google Scholar
• Pacher P, Kecskemeti V. 2004. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des. 10:2463–2475.
   PubMed Web of Science ®Google Scholar
• Pae CU, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS. 2014. Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram. Expert Opin Drug Saf. 13:197–205.
   PubMed Web of Science ®Google Scholar
• Ramasubbu R, Taylor VH, Samaan Z, Sockalingham S, Li M, Patten S, Rodin G, Schaffer A, Beaulieu S, Mcintyre RS. 2012. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry. 24:91–109.
   PubMed Web of Science ®Google Scholar
• Ratheesh A, Davey C, Hetrick S, Alvarez-Jimenez M, Voutier C, Bechdolf A, Mcgorry PD, Scott J, Berk M, Cotton SM. 2017. A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder. Acta Psychiatr Scand. 135:273–284.
   PubMed Web of Science ®Google Scholar
• Rauma PH, Honkanen RJ, Williams LJ, Tuppurainen MT, Kroger HP, Koivumaa-Honkanen H. 2016. Effects of antidepressants on postmenopausal bone loss – A 5-year longitudinal study from the OSTPRE cohort. Bone. 89:25–31.
   PubMed Web of Science ®Google Scholar
• Rauma PH, Pasco JA, Berk M, Stuart AL, Koivumaa-Honkanen H, Honkanen RJ, Hodge JM, Williams LJ. 2015. The association between use of antidepressants and bone quality using quantitative heel ultrasound. Aust N Z J Psychiatry. 49:437–443.
   PubMed Web of Science ®Google Scholar
• Richard IH, Mcdermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, et al. 2012. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 78:1229–1236.
   PubMed Web of Science ®Google Scholar
• Rivelli S, Jiang W. 2007. Depression and ischemic heart disease: what have we learned from clinical trials? Curr Opin Cardiol. 22:286–291.
   PubMed Web of Science ®Google Scholar
• Roose SP, Glassman AH, Giardina EG, Walsh BT, Woodring S, Bigger JT. 1987. Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry. 44:273–275.
   PubMed Web of Science ®Google Scholar
• Selzer ML. 1971. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry. 127:1653–1658.
   PubMed Web of Science ®Google Scholar
• Servier Laboratories. 2014. Valdoxan Product Information – Verion 15g. Available at http://secure.healthlinks.net.au/content/servier/pi.cfm?product=sepvaldx [Accessed 5th November 2015].
   Google Scholar
• Shacham E, Nurutdinova D, Satyanarayana V, Stamm K, Overton ET. 2009. Routine screening for depression: identifying a challenge for successful HIV care. AIDS Patient Care STDS. 23:949–955.
   PubMed Web of Science ®Google Scholar
• Shelton C. 2009. Factors impacting the selection of antidepressant treatment in patients with major depressive disorder at risk for nonadherence. CNS Spectr. 14:15–19.
   PubMed Web of Science ®Google Scholar
• Shin JY, Park MJ, Lee SH, Choi SH, Kim MH, Choi NK, Lee J, Park BJ. 2015. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ. 351:h3517.
   PubMedGoogle Scholar
• Silins E, Copeland J, Dillon P. 2007. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. Aust N Z J Psychiatry. 41:649–655.
   PubMed Web of Science ®Google Scholar
• Singh AB, Bousman CA. 2017. Antidepressant pharmacogenetics. Am J Psychiatry. 174:417–418.
   PubMed Web of Science ®Google Scholar
• Snyder HR. 2013. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull 139:81–132.
   PubMed Web of Science ®Google Scholar
• Spindelegger CJ, Papageorgiou K, Grohmann R, Engel R, Greil W, Konstantinidis A, Agelink MW, Bleich S, Ruether E, Toto S, et al. 2014. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Int J Neuropsychopharmacol. 18:pyu080.
   PubMed Web of Science ®Google Scholar
• Stryjer R, Spivak B, Strous RD, Shiloh R, Harary E, Polak L, Birgen M, Kotler M, Weizman A. 2009. Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study. Clin Neuropharmacol. 32:82–84.
   PubMed Web of Science ®Google Scholar
• Stuart AL, Mohebbi M, Pasco JA, Quirk SE, Brennan-Olsen SL, Berk M, Williams LJ. 2017. Pattern of psychotropic medication use over two decades in Australian women. Aust N Z J Psychiatry. [accessed 2017 May 1]. DOI:10.1177/0004867417704056
   Web of Science ®Google Scholar
• Swann AC, Lafer B, Perugi G, Frye MA, Bauer M, Bahk WM, Scott J, Ha K, Suppes T. 2013. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry. 170:31–42.
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Rudkin L, Bullemor Day P, Lubin J, Chukwujekwu C, Hawton K. 2013. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 5:CD003382.
   Google Scholar
• Teply RM, Packard KA, White ND, Hilleman DE, Dinicolantonio JJ. 2016. Treatment of depression in patients with concomitant cardiac disease. Prog Cardiovasc Dis. 58:514–528.
   PubMed Web of Science ®Google Scholar
• Thanacoody HK, Thomas SH. 2005. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev 24:205–214.
   PubMedGoogle Scholar
• Thase ME, Fayyad R, Cheng RF, Guico-Pabia CJ, Sporn J, Boucher M, Tourian KA. 2015. Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis. Curr Med Res Opin. 31:809–820.
   PubMed Web of Science ®Google Scholar
• Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, Kozel D, Hauser J, Souery D, Placentino A, et al. 2009. Adverse reactions to antidepressants. Br J Psychiatry. 195:202–210.
   PubMed Web of Science ®Google Scholar
• Veith RC, Raskind MA, Caldwell JH, Barnes RF, Gumbrecht G, Ritchie JL. 1982. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med. 306:954–959.
   PubMed Web of Science ®Google Scholar
• Vieweg WV, Wood MA. 2004. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics. 45:371–377.
   PubMed Web of Science ®Google Scholar
• Voican CS, Corruble E, Naveau S, Perlemuter G. 2014. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry. 171:404–415.
   PubMed Web of Science ®Google Scholar
• Werneke U, Jamshidi F, Taylor DM, Ott M. 2016. Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases. BMC Neurol. 16:97.
   PubMed Web of Science ®Google Scholar
• Williams LJ, Henry MJ, Berk M, Dodd S, Jacka FN, Kotowicz MA, Nicholson GC, Pasco JA. 2008. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol. 23:84–87.
   PubMed Web of Science ®Google Scholar
• Williams LJ, Pasco JA, Hodge JM, Berk M. 2016. Is there a nexus between mental and bone health? Aust N Z J Psychiatry. 50:829–830.
   PubMedGoogle Scholar
• Williams LJ, Pasco JA, Jacka FN, Hodge JM, Kotowicz MA, Berk M. 2013. Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders. J Affect Disord. 146:395–400.
   PubMed Web of Science ®Google Scholar
• Williams LJ, Pasco JA, Stuart AL, Jacka FN, Brennan SL, Dobbins AG, Honkanen R, Koivumaa-Honkanen H, Rauma PH, Berk M. 2015. Psychiatric disorders, psychotropic medication use and falls among women: an observational study. BMC Psychiatry. 15:75.
   PubMed Web of Science ®Google Scholar
• Wise TN, Perahia DG, Pangallo BA, Losin WG, Wiltse CG. 2006. Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies. Prim Care Companion J Clin Psychiatry. 8:269–278.
   PubMedGoogle Scholar
• Wolkowitz OM, Burke H, Epel ES, Reus VI. 2009. Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci 1179:19–40.
   PubMed Web of Science ®Google Scholar
• Woo YS, Seo HJ, Mcintyre RS, Bahk WM. 2016. Obesity and its potential effects on antidepressant treatment outcomes in patients with depressive disorders: a literature review. Int J Mol Sci. 17:E80.
   PubMed Web of Science ®Google Scholar
• Wright SL, Persad C. 2007. Distinguishing between depression and dementia in older persons: neuropsychological and neuropathological correlates. J Geriatr Psychiatry Neurol. 20:189–198.
   PubMed Web of Science ®Google Scholar
• Yekehtaz H, Farokhnia M, Akhondzadeh S. 2013. Cardiovascular considerations in antidepressant therapy: an evidence-based review. J Tehran Heart Cent 8:169–176.
   PubMedGoogle Scholar
• Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. 2009. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 31:403–413.
   PubMed Web of Science ®Google Scholar